Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Cite this paper

@article{Grothey2013RegorafenibMF, title={Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.}, author={Axel M Grothey and Eric Van Cutsem and Alberto F. Sobrero and Salvatore Siena and Alfredo Falcone and Marc Ychou and Yves Humblet and Olivier Bouch{\'e} and Laurent Mineur and Carlo Barone and Antoine A. Adenis and Josep Tabernero and Takayuki Yoshino and Marta Schirripa and Richard M. Goldberg and Daniel J. Sargent and Frank Cihon and Lisa D. Cupit and A. Byon - Wagner and Dirk Laurent}, journal={Lancet}, year={2013}, volume={381 9863}, pages={303-12} }